STOK (STOCKS)
Stoke Therapeutics, Inc. Common Stock
$31.150000
-1.820000 (-5.52%)
Prev close: $32.970000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Ian Frederick Smith
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,252.66M
- Employees
- 128
- P/E (TTM)
- -9.78
- P/B (TTM)
- 5.95
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.93 | $-0.81 | -0.1188 | -14.65% |
|
Mar 2026 (Q1)
|
$-0.79 | $-0.84 | +0.0535 | +6.34% |
|
Dec 2025 (Q4)
|
$-0.97 | $-0.73 | -0.2421 | -33.26% |
|
Sep 2025 (Q3)
|
$-0.65 | $-0.58 | -0.0703 | -12.13% |
Financial Statements
| Revenues | $27.59M |
| Benefits Costs and Expenses | $236.77M |
| Costs And Expenses | $236.77M |
| Nonoperating Income/Loss | $14.20M |
| Operating Expenses | $250.97M |
| Selling, General, and Administrative Expenses | $82.40M |
| Research and Development | $168.57M |
| Operating Income/Loss | -$223.38M |
| Income/Loss From Continuing Operations After Tax | -$207.90M |
| Income/Loss From Continuing Operations Before Tax | -$209.18M |
| Income Tax Expense/Benefit | -$1.28M |
| Interest Expense, Operating | $47.00K |
| Net Income/Loss | -$207.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$207.90M |
| Net Income/Loss Available To Common Stockholders, Basic | -$207.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.37 |
| Diluted Earnings Per Share | -$3.34 |
| Basic Average Shares | 188,633,451 |
| Diluted Average Shares | 186,514,582 |
| Assets | $393.97M |
| Current Assets | $322.54M |
| Prepaid Expenses | $14.69M |
| Other Current Assets | $307.85M |
| Noncurrent Assets | $71.43M |
| Fixed Assets | $4.83M |
| Other Non-current Assets | $66.60M |
| Liabilities | $48.42M |
| Current Liabilities | $41.93M |
| Accounts Payable | $4.79M |
| Other Current Liabilities | $37.14M |
| Noncurrent Liabilities | $6.49M |
| Equity | $345.55M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $345.55M |
| Liabilities And Equity | $393.97M |
| Net Cash Flow From Operating Activities | -$177.99M |
| Net Cash Flow From Operating Activities, Continuing | -$177.99M |
| Net Cash Flow From Investing Activities | $7.75M |
| Net Cash Flow From Investing Activities, Continuing | $7.75M |
| Net Cash Flow From Financing Activities | $181.70M |
| Net Cash Flow From Financing Activities, Continuing | $181.70M |
| Net Cash Flow | $11.46M |
| Net Cash Flow, Continuing | $11.46M |
| Comprehensive Income/Loss | -$208.54M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$208.54M |
| Other Comprehensive Income/Loss | -$638.00K |